Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
9 "Research"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Periodontitis and non-communicable diseases in a Brazilian population, a cross-sectional study, Vila Velha-ES, Brazil
Gustavo Vital de Mendonça, Crispim Cerutti Junior, Alfredo Carlos Rodrigues Feitosa, Brígida Franco Sampaio de Mendonça, Lucia Helena Sagrillo Pimassoni
Osong Public Health Res Perspect. 2024;15(3):212-220.   Published online June 27, 2024
DOI: https://doi.org/10.24171/j.phrp.2024.0021
  • 337 View
  • 13 Download
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Objectives
The objective of this study was to examine the hypothesis that periodontal disease is associated with chronic non-communicable diseases. Methods: In this cross-sectional study, we evaluated the periodontal health condition of the population, based on the community periodontal index, as well as the number of missing teeth and the presence of systemic health conditions. We quantified the association between oral health and the presence of chronic diseases using simple logistic regression, adjusting for confounding factors including age, smoking, and overweight. Results: The study population consisted of 334 volunteers, aged between 19 and 81 years. In patients over 45 years old, periodontal disease was found to be significantly associated with hypertension and diabetes. Furthermore, in female patients, periodontal disease was significantly associated with hypertension, diabetes, and cancer. Conclusion: Our findings indicate that periodontal disease is positively and significantly associated with both arterial hypertension and diabetes, independent of potential confounding factors.
Special Articles
The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea
Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Jaehun Jung, Joongyub Lee, Ju-Young Shin, Sun-Young Jung, Byung-Joo Park, Nam-Kyong Choi
Osong Public Health Res Perspect. 2024;15(2):97-106.   Published online April 4, 2024
DOI: https://doi.org/10.24171/j.phrp.2023.0343
  • 1,852 View
  • 86 Download
  • 1 Web of Science
  • 1 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDF
The COVID-19 Vaccine Safety Research Committee (CoVaSC) was established in November 2021 to address the growing need for independent, in-depth scientific evidence on adverse events (AEs) following coronavirus disease 2019 (COVID-19) vaccination. This initiative was requested by the Korea Disease Control and Prevention Agency and led by the National Academy of Medicine of Korea. In September 2022, the COVID-19 Vaccine Safety Research Center was established, strengthening CoVaSC’s initiatives. The center has conducted various studies on the safety of COVID-19 vaccines. During CoVaSC’s second research year, from September 29, 2022 to July 19, 2023, the center was restructured into 4 departments: Epidemiological Research, Clinical Research, Communication & Education, and International Cooperation & Policy Research. Its main activities include (1) managing CoVaSC and the COVID-19 Vaccine Safety Research Center, (2) surveying domestic and international trends in AE causality investigation, (3) assessing AEs following COVID-19 vaccination, (4) fostering international collaboration and policy research, and (5) organizing regular fora and training sessions for the public and clinicians. Causality assessments have been conducted for 27 diseases, and independent research has been conducted after organizing ad hoc committees comprising both epidemiologists and clinical experts on each AE of interest. The research process included protocol development, data analysis, interpretation of results, and causality assessment. These research outcomes have been shared transparently with the public and healthcare experts through various fora. The COVID-19 Vaccine Safety Research Center plans to continue strengthening and expanding its research activities to provide reliable, high-quality safety information to the public.

Citations

Citations to this article as recorded by  
  • SARS-CoV-2-Vaccine-Related Endocrine Disorders: An Updated Narrative Review
    Avraham Ishay, Kira Oleinikov, Elena Chertok Shacham
    Vaccines.2024; 12(7): 750.     CrossRef
A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee
Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Byung-Joo Park, Nam-Kyong Choi
Osong Public Health Res Perspect. 2023;14(1):5-14.   Published online February 28, 2023
DOI: https://doi.org/10.24171/j.phrp.2023.0026
  • 3,597 View
  • 165 Download
  • 7 Web of Science
  • 5 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDF
With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events. Accordingly, the COVID-19 Vaccine Safety Research Committee (CoVaSC) was launched in November 2021 to perform safety studies and establish evidence for policy guidance. The CoVaSC established 3 committees for epidemiology, clinical research, and communication. The CoVaSC mainly utilizes pseudonymized data linking KDCA’s COVID-19 vaccination data and the National Health Insurance Service’s claims data. The CoVaSC’s 5-step research process involves defining the target diseases and organizing ad-hoc committees, developing research protocols, performing analyses, assessing causal relationships, and announcing research findings and utilizing them to guide compensation policies. As of 2022, the CoVaSC completed this research process for 15 adverse events. The CoVaSC launched the COVID-19 Vaccine Safety Research Center in September 2022 and has been reorganized into 4 divisions to promote research including international collaborative studies, long-/short-term follow-up studies, and education programs. Through these enhancements, the CoVaSC will continue to swiftly provide scientific evidence for COVID-19 vaccine research and compensation and may serve as a model for preparing for future epidemics of new diseases.

Citations

Citations to this article as recorded by  
  • Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis
    Ju Hwan Kim, Dongwon Yoon, Hwa Yeon Ko, Kyungyeon Jung, Jun-Sang Sunwoo, Won Chul Shin, Jung-Ick Byun, Ju-Young Shin
    BMC Medicine.2024;[Epub]     CrossRef
  • The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea
    Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Jaehun Jung, Joongyub Lee, Ju-Young Shin, Sun-Young Jung, Byung-Joo Park, Nam-Kyong Choi
    Osong Public Health and Research Perspectives.2024; 15(2): 97.     CrossRef
  • A Causality Assessment Framework for COVID-19 Vaccines and Adverse Events at the COVID-19 Vaccine Safety Research Center
    Seyoung Kim, Jeong Ah Kim, Hyesook Park, Sohee Park, Sanghoon Oh, Seung Eun Jung, Hyoung-Shik Shin, Jong Koo Lee, Hee Chul Han, Jun Hee Woo, Byung-Joo Park, Nam-Kyong Choi, Dong-Hyun Kim
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • To become a more stronger and safer country
    Jong-Koo Lee
    Osong Public Health and Research Perspectives.2023; 14(2): 67.     CrossRef
  • Risk of lymphadenopathy from SARS-CoV-2 vaccination in Korea: a self-controlled case series analysis
    Mi-Sook Kim, Bongyoung Kim, Jeong Pil Choi, Nam-Kyong Choi, Jung Yeon Heo, Jun Yong Choi, Joongyub Lee, Sang Il Kim
    Epidemiology and Health.2023; 45: e2023090.     CrossRef
Original Articles
High Tobacco Use among Presumptive Tuberculosis Patients, South India: Time to Integrate Control of Two Epidemics
Kunal Pradip Kanakia, Marie Gilbert Majella, Pruthu Thekkur, Gomathi Ramaswamy, Divya Nair, Palanivel Chinnakali
Osong Public Health Res Perspect. 2016;7(4):228-232.   Published online August 31, 2016
DOI: https://doi.org/10.1016/j.phrp.2016.06.001
  • 3,356 View
  • 27 Download
  • 6 Crossref
AbstractAbstract PDF
Objectives
Tobacco is an important risk factor for tuberculosis (TB) infection and TB disease. Identifying tobacco users and providing tobacco cessation services is expected to reduce the burden of TB. We assessed tobacco use among presumptive TB patients attending a tertiary hospital and their willingness to attend tobacco cessation services.
Methods
A cross-sectional study was conducted among presumptive TB patients attending a designated microscopy center of a tertiary hospital in South India. All presumptive TB patients aged ≥ 18 years attending the designated microscopy center were interviewed using a semistructured interview schedule. Data on presumptive TB patient's age, sex, tobacco use and forms of tobacco, attempts to quit tobacco since 1 year, and willingness to attend a smoking cessation clinic in tertiary hospital were captured. History of use of tobacco in the past 1 month was considered as “tobacco use.”.
Results
A total of 424 presumptive TB patients aged ≥ 18 years were interviewed. Tobacco use in the past 1 month was reported by 176 (41.5%, 95% confidence interval: 36.9–46.3%) presumptive TB patients. In total, 78 (18%) presumptive TB patients were eventually diagnosed with smear-positive pulmonary TB, of them 63 (80%) were tobacco users. Presumptive TB patients aged ≥ 30 years, male sex, and < 10 years of education were significantly associated with tobacco use. Of 176, a majority of 132 (75%) used some form of smoking. Of a total of 132 smokers, 70 (53%) were willing to avail of tobacco cessation services.
Conclusion
Tobacco use among presumptive TB patients was high. Considering the high willingness to quit among smokers, proven brief interventions to help quit smoking can be tried.

Citations

Citations to this article as recorded by  
  • Smoking cessation interventions in South Asian Region: a systematic scoping review
    Sajid Iqbal, Rubina Barolia, Pammla Petrucka, Laila Ladak, Rameesha Rehmani, Abdul Kabir
    BMC Public Health.2022;[Epub]     CrossRef
  • Tobacco use and nicotine dependence among newly diagnosed pulmonary tuberculosis patients in Ballabgarh tuberculosis unit, Haryana
    Rakesh Kumar, Shashi Kant, Ankit Chandra, Anand Krishnan
    Journal of Family Medicine and Primary Care.2020; 9(6): 2860.     CrossRef
  • A narrative review of facilitators and barriers to smoking cessation and tobacco-dependence treatment in patients with tuberculosis in low- and middle-income countries
    Kamila Zvolska, Alexandra Pankova, Iveta Nohavova, Rumana Huque, Helen Elsey, Melanie Boeckmann, Aziz Sheikh, Kamran Siddiqi, Eva Kralikova
    Tobacco Induced Diseases.2020;[Epub]     CrossRef
  • Effective Counseling: A Major Challenge of Tuberculosis Control Programme in Tackling the Dual Disease Burden of Tobacco Consumption among Tuberculosis Patients in India
    Bidhata Khatri, K.K. Shyamala, Nehal LNU, Supriya Tiwari
    Indian Journal of Respiratory Care.2020; 9(1): 77.     CrossRef
  • Characteristics and sputum conversion of tuberculosis (TB) patients in Kalutara, Sri Lanka
    Sumal Nandasena, Chaminda Senavirathna, Champa Munasinghe, Chapa Wijesena, Ridmi Sucharitharathna
    Indian Journal of Tuberculosis.2019; 66(1): 76.     CrossRef
  • Tuberculosis and cigarette smoke exposure: An update ofin vitroandin vivostudies
    Y. López-Hernández, C. E. Rivas-Santiago, J. A. López, G. Mendoza-Almanza, R. Hernandez-Pando
    Experimental Lung Research.2018; 44(2): 113.     CrossRef
The Determinants of Research and Development Investment in the Pharmaceutical Industry: Focus on Financial Structures
Munjae Lee, Mankyu Choi
Osong Public Health Res Perspect. 2015;6(5):302-309.   Published online October 31, 2015
DOI: https://doi.org/10.1016/j.phrp.2015.10.013
  • 2,938 View
  • 17 Download
  • 22 Crossref
AbstractAbstract PDF
Objectives
This study analyzes the influence of the financial structure of pharmaceutical companies on R&D investment to create a next-generation profit source or develop relatively cost-effective drugs to maximize enterprise value.
Methods
The period of the empirical analysis is from 2000 to 2012. Financial statements and comments in general and internal transactions were extracted from TS-2000 of the Korea Listed Company Association (KLCA), and data related to stock price is extracted from KISVALUE-Ⅲ of NICE Information Service Co., Ltd. Stata 12.0 was used as the statistical package for panel analysis.
Results
The current ratio had a positive influence on R&D investment, the debt ratio had a negative influence on R&D investment, and return on investment and net sales growth rate did not have a significant influence on R&D investment.
Conclusion
It was found in this study that the higher liquidity ratio, the greater the R&D investment. The stability of pharmaceutical companies has a negative influence on R&D investment. This finding is consistent with the prediction that if a company faces a financial risk, it will be passive in R&D investment due to its financial difficulties.

Citations

Citations to this article as recorded by  
  • How Indian Pharma Industry Performed in the Last Decade? Impact of a Non-macroeconomic Variable and Financial Distress
    Pooja Singh, Anindita Chakraborty
    Jindal Journal of Business Research.2023; 12(2): 143.     CrossRef
  • How structural changes are driving R&D activity in India’s pharmaceutical sector
    Niloufer Sohrabji, Kristen Marquette
    Journal of Pharmaceutical Health Services Research.2023; 14(3): 256.     CrossRef
  • Patent and Marketing Exclusivities 101 for Drug Developers
    Bryan Oronsky, Scott Caroen, Franck Brinkhaus, Tony Reid, Meaghan Stirn, Raj Kumar
    Recent Patents on Biotechnology.2023; 17(3): 257.     CrossRef
  • The driving process of technological innovation in construction: a firm-level CDM analysis
    Zheng Gong, Nannan Wang
    Construction Innovation .2022; 22(2): 222.     CrossRef
  • Envisioning the challenges of the pharmaceutical sector in the Indian health-care industry: a scenario analysis
    Giuseppe Festa, Ashutosh Kolte, Maria Rosaria Carli, Matteo Rossi
    Journal of Business & Industrial Marketing.2022; 37(8): 1662.     CrossRef
  • Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design
    Yu-Fei Hua, Jin Lu, Bing Bai, Han-Qing Zhao
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Ambidexterity's influence on export strategy development—The case of the Indian pharmaceutical industry
    Ashutosh Kolte, Giuseppe Festa, Matteo Rossi, Alkis Thrassou, Demetris Vrontis, Michael Christofi
    Thunderbird International Business Review.2022; 64(5): 465.     CrossRef
  • Local pharmaceutical research and development capacity in a developing country: a qualitative exploration of perspectives from key stakeholders in Ethiopia
    Muluken Nigatu Selam, Samuel Abera, Helen Geremew, Eskinder Eshetu Ali
    Journal of Pharmaceutical Policy and Practice.2022;[Epub]     CrossRef
  • Optimization and Quest of HPMC loaded Stavudine Controlled Release Dosage Development by Central Composite Design utilizing Reduced Factorial Screening Technique
    Jyothsna Gangolu, Sandyapakula Balaiah, Sisir Nandi, Harekrishna Roy
    Brazilian Journal of Pharmaceutical Sciences.2022;[Epub]     CrossRef
  • The contribution of intellectual capital to financial stability in Indian pharmaceutical companies
    Giuseppe Festa, Matteo Rossi, Ashutosh Kolte, Luca Marinelli
    Journal of Intellectual Capital.2021; 22(2): 337.     CrossRef
  • Factors affecting profitability of pharmaceutical company: an Indonesian evidence
    Harianto Lim, Rofikoh Rokhim
    Journal of Economic Studies.2021; 48(5): 981.     CrossRef
  • Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model
    Jingyuan Yang, Ling Wang, Ziyuan Sun, Fangming Zhu, Yihui Guo, Yan Shen
    International Journal of Environmental Research an.2021; 18(21): 11560.     CrossRef
  • Drivers of ICT investments in bakery and sugar confectionery processed food sub-sector in India
    Navyashree GR, Savita Bhat
    Journal of Agribusiness in Developing and Emerging.2020; 10(2): 191.     CrossRef
  • Gouvernance et intensité d’innovation dans les ETI innovantes
    Léopold Djoutsa Wamba, Éric Braune, Frédéric Teulon
    Management & Avenir.2020; N° 118(4): 111.     CrossRef
  • MALİYET YAPIŞKANLIĞININ YENİDEN GÖZDEN GEÇİRİLMESİ: BORSA İSTANBUL İMALAT SANAYİ ÖRNEĞİ
    Mehmet Emin KARABAYIR
    Muhasebe ve Vergi Uygulamaları Dergisi.2019; 12(2): 317.     CrossRef
  • Bioaugmentation effect of Aeromonas hydrophila and Pseudomonas putida on kinetics of activated sludge process in treating pharmaceutical industrial wastewater
    Marija Vuković Domanovac, Monika Šabić Runjavec, Ernest Meštrović
    Journal of Chemical Technology & Biotechnology.2019; 94(8): 2721.     CrossRef
  • Replicating the R&D investments and financial structure relationship: evidence from Borsa İstanbul
    Nasif Ozkan
    Management Review Quarterly.2018; 68(4): 399.     CrossRef
  • Firm level R&D intensity: evidence from Indian drugs and pharmaceutical industry
    Shilpi Tyagi, D. K. Nauriyal, Rachita Gulati
    Review of Managerial Science.2018; 12(1): 167.     CrossRef
  • Impact of investment in intangible assets on corporate performance in India
    Aparna Bhatia, Khushboo Aggarwal
    International Journal of Law and Management.2018; 60(5): 1058.     CrossRef
  • Relation of R&D expense to turnover and number of listed companies in all industrial fields
    Jun-Hwan Park, Bangrae Lee, Yeong-Ho Moon, GyuSeok Kim, Lee-Nam Kwon
    Journal of Open Innovation: Technology, Market, an.2018; 4(1): 1.     CrossRef
  • Policy to encourage the development of antimicrobials
    Ayman Chit, Paul Grootendorst
    International Journal of Health Governance.2018; 23(2): 101.     CrossRef
  • O IMPACTO DOS INVESTIMENTOS EM P&D NO DESEMPENHO DAS EMPRESAS: APLICAÇÕES NO USO DE REGRESSÃO QUANTÍLICA COM VARIÁVEIS INSTRUMENTAIS
    Leonardo Andrade Rocha, Ahmad Saeed Khan, Patrícia Verônica Pinheiro Sales Lima, Maria Ester Soares Dal Poz, Carlos Alano Soares de Almeida
    Revista de Economia Contemporânea.2018;[Epub]     CrossRef
Impact of Corporate Governance on Research and Development Investment in the Pharmaceutical Industry in South Korea
Munjae Lee
Osong Public Health Res Perspect. 2015;6(4):249-255.   Published online August 31, 2015
DOI: https://doi.org/10.1016/j.phrp.2015.07.003
  • 3,058 View
  • 21 Download
  • 4 Crossref
AbstractAbstract PDF
Objectives
The purpose of this study is to analyze the influence of the corporate governance of pharmaceutical companies on research and development (R&D) investment.
Methods
The period of the empirical analysis is from 2000 to 2012. Financial statements and comments in general, and internal transactions were extracted from TS-2000 of the Korea Listed Company Association. Sample firms were those that belong to the medical substance and drug manufacturing industries. Ultimately, 786 firm-year data of 81 firms were included in the sample (unbalanced panel data).
Results
The shareholding ratio of major shareholders and foreigners turned out to have a statistically significant influence on R&D investment (p < 0.05). No statistical significance was found in the shareholding ratio of institutional investors and the ratio of outside directors.
Conclusion
The higher the shareholding ratio of the major shareholders, the greater the R&D investment. There will be a need to establish (or switch to) a holding company structure. Holding companies can directly manage R&D in fields with high initial risks, and they can diversify these risks. The larger the number of foreign investors, the greater the R&D investment, indicating that foreigners directly or indirectly impose pressure on a manager to make R&D investments that bring long-term benefits.

Citations

Citations to this article as recorded by  
  • EFFECT OF CORPORATE GOVERNANCE PRACTICES ON R&D AND INNOVATION COSTS: A CASE STUDY ON BORSA İSTANBUL
    Hüseyin Ali KUTLU, Bekir GEREKAN
    Muhasebe ve Vergi Uygulamaları Dergisi.2021; 14(3): 967.     CrossRef
  • Corporate governance and the environment in the health sector: Systematic literature review
    Isabel Cristina Panziera Marques, Zélia Maria da Silva Serrasqueiro Teixeira, Fernanda Maria Duarte Nogueira
    Journal of Governance and Regulation.2020; 9(2): 8.     CrossRef
  • Gouvernance et intensité d’innovation dans les ETI innovantes
    Léopold Djoutsa Wamba, Éric Braune, Frédéric Teulon
    Management & Avenir.2020; N° 118(4): 111.     CrossRef
  • Differentiation of innovation strategies based on pharmaceutical licensing agreements: Insight from Korean pharmaceutical firms
    Chie Hoon Song, Jens Leker
    Technology Analysis & Strategic Management.2019; 31(2): 169.     CrossRef
Analysis on Time-Lag Effect of Research and Development Investment in the Pharmaceutical Industry in Korea
Munjae Lee, Mankyu Choi
Osong Public Health Res Perspect. 2015;6(4):241-248.   Published online August 31, 2015
DOI: https://doi.org/10.1016/j.phrp.2015.07.001
  • 2,981 View
  • 16 Download
  • 15 Crossref
AbstractAbstract PDF
Objectives
The aim of this study is to analyze the influence of the research and development (R&D) investment of pharmaceutical companies on enterprise value.
Methods
The period of the empirical analysis is from 2000 to 2012, considering the period after the influence of the financial crisis. Financial statements and comments in general and internal transactions were extracted from TS-2000 of the Korea Listed Company Association, and data related to stock price were extracted from KISVALUE-III of National Information and Credit Evaluation Information Service Co., Ltd. STATA 12.0 was used as the statistical package for panel analysis.
Results
In the pharmaceutical firms, the influence of the R&D intensity with regard to Tobin's q was found to be positive. However, only the R&D expenditure intensities of previous years 2 and 5 (t–2 and t–5, respectively) were statistically significant (p < 0.1), whereas those of previous years 1, 3, and 4 years (t–1, t–3, and t–4, respectively) were not statistically significant.
Conclusion
R&D investment not only affects the enterprise value but is also evaluated as an investment activity that raises the long-term enterprise value. The research findings will serve as valuable data to understand the enterprise value of the Korea pharmaceutical industry and to strengthen reform measures. Not only should new drug development be made, but also investment and support should be provided according to the specific factors suitable to improve the competitiveness of each company, such as generic, incrementally modified drugs, and biosimilar products.

Citations

Citations to this article as recorded by  
  • R&D investment and corporate total factor productivity under the heterogeneous environmental regulations: evidence from Chinese micro firms
    X. Ding, Y. Zhang, Y. Fu, Z. Xu
    International Journal of Environmental Science and.2024;[Epub]     CrossRef
  • A new perspective for European SMEs’ innovative support analysis: Does non-financial support matter?
    Solomon Gyamfi, Wolfgang Gerstlberger, Viktor Prokop, Jan Stejskal
    Heliyon.2024; 10(1): e23796.     CrossRef
  • R&D activity and firm performance: mapping the field
    Kseniia Boiko
    Management Review Quarterly.2022; 72(4): 1051.     CrossRef
  • Pharmaceutical industry in export marketing: a closer look at competitiveness
    Mehdi Mohammadzadeh, Nima Bakhtiari, Reza Safarey, Tayebeh Ghari
    International Journal of Pharmaceutical and Health.2021; 13(3): 331.     CrossRef
  • The effect of intangible assets on sustainable growth and firm value – Evidence on intellectual capital investment in companies listed on Bucharest Stock Exchange
    Catalin Ionita, Elena Dinu
    Kybernetes.2021; 50(10): 2823.     CrossRef
  • AR-GE GİDERLERİ İLE KÂRLILIK VE BÜYÜME ARASINDA NEDENSELLİK İLİŞKİSİ: BIST ÜZERİNE BİR İNCELEME
    Mehmet DİKİCİ, Kadir GÜRDAL
    Muhasebe ve Vergi Uygulamaları Dergisi.2021; 14(3): 1193.     CrossRef
  • R&D Investments, Debt Capital, and Ownership Concentration: A Three-Way Interaction and Lag Effects on Firm Performance in China's Pharmaceutical Industry
    Chih-Yi Su, Yao-Ning Guo, Kuang-Cheng Chai, Wei-Wei Kong
    Frontiers in Public Health.2021;[Epub]     CrossRef
  • R&D SPENDING AND FINANCIAL PERFORMANCE: AN INVESTIGATION IN AN EMERGING MARKET
    Nasıf ÖZKAN
    International Journal of Management Economics and .2021;[Epub]     CrossRef
  • The persistence of current market valuation of future capital investment
    Nancy Beneda
    Journal of Corporate Accounting & Finance.2020; 31(3): 163.     CrossRef
  • Sustainability assessment of universities as small-scale urban systems: A comparative analysis using Fisher Information and Data Envelopment Analysis
    Ning Ai, Marc Kjerland, Cynthia Klein-Banai, Thomas L. Theis
    Journal of Cleaner Production.2019; 212: 1357.     CrossRef
  • Analysing future change in the EU's energy innovation system
    Yeong Jae Kim, Charlie Wilson
    Energy Strategy Reviews.2019; 24: 279.     CrossRef
  • A review of three years' experience of the first pharmacometrics company in Korea
    So Jin Lee, Sangil Jeon
    Translational and Clinical Pharmacology.2019; 27(4): 149.     CrossRef
  • The impact of inter-industry R&D technology spillover on carbon emission in China
    Jianling Jiao, Yufei Yang, Yu Bai
    Natural Hazards.2018; 91(3): 913.     CrossRef
  • Characteristics of Corporate R&D Investment in Emerging Markets: Evidence from Manufacturing Industry in China and South Korea
    Jian Xu, Jae-Woo Sim
    Sustainability.2018; 10(9): 3002.     CrossRef
  • R&D Investments, EPO Patent Applications and the Economic Heterogeneity within the EU
    Zuzana Potužáková, Jan Öhm
    Review of Economic Perspectives.2018; 18(2): 177.     CrossRef
Experiences in Healthy Dieting of Male College Students with Obesity in Korea
Jeong Soo Kim
Osong Public Health Res Perspect. 2015;6(1):59-63.   Published online February 28, 2015
DOI: https://doi.org/10.1016/j.phrp.2014.11.008
  • 2,679 View
  • 18 Download
AbstractAbstract PDF
Objectives
The purpose of this study was to describe and understand experiences of healthy dieting in male college students with obesity.
Methods
The interview data were collected from nine male students and analyzed by using descriptive phenomenology of Colaizzi. The procedural steps described the phenomenon of interest, collected participants' descriptions of the phenomenon, extracted the meaning of significant statements, organized the meanings into clusters, wrote exhaustive descriptions, and then incorporated data into an exhaustive description.
Results
The findings in 246 restatements, 47 constructed meanings, 31 themes, eight theme clusters, and four categories were deduced. The four categories were “Uneasiness at interpersonal relationships”, “Developing durability in dieting strategies”, “Practicing healthy diets based on information”, and “Perceived on healthy diets as a whole health support strategies”.
Conclusion
This study described experiences in healthy dieting of male college students who were discharged from military services. These findings have important implications for understanding healthy dieting in young men and must be considered in developing health promotion in youth.
Experiences of Health Related Lifestyles in High Body Fat but Non-obese Female College Students in Korea
Jeongsoo Kim
Osong Public Health Res Perspect. 2014;5(1):68-73.   Published online February 28, 2014
DOI: https://doi.org/10.1016/j.phrp.2014.01.004
  • 4,934 View
  • 22 Download
  • 2 Crossref
AbstractAbstract PDF
Objectives
The purpose of this study was to describe and understand the lifestyles of non-obese female college students with high body fat (HBF).
Methods
The interview data were collected from 18 female students [body mass index (BMI) <23 kg/m2 and body fat ratio ≥30%] and analyzed by using descriptive phenomenology of Colaizzi. The procedural steps described the phenomenon of interest, collected participants' descriptions of the phenomenon, extracted the meaning of significant statements, organized the meanings into clusters, wrote exhaustive descriptions and then incorporated data into an exhaustive description.
Results
The results in 153 restatements, 36 constructed meanings, 22 themes, seven theme clusters, and three categories were deduced. The three categories were: diminished daily concerns of health, changes in living habits by stressors, and perceived unbalance in health.
Conclusion
This study describes non-obese female university students' experiences with HBF and their lifestyles. The findings have important implications for health promotion for non-obese female university students with HBF and must be considered when developing education courses for preparing adults.

Citations

Citations to this article as recorded by  
  • The effect of physical activity intervention and nutritional habits on anthropometric measures in elementary school children: the health oriented pedagogical project (HOPP)
    Nandu Goswami, Irhad Trozic, Maren Valand Fredriksen, Per Morten Fredriksen
    International Journal of Obesity.2021; 45(8): 1677.     CrossRef
  • Experiences in Healthy Dieting of Male College Students with Obesity in Korea
    Jeong Soo Kim
    Osong Public Health and Research Perspectives.2015; 6(1): 59.     CrossRef

PHRP : Osong Public Health and Research Perspectives